This announcement is a separate document:
天津發展：須予披露交易 - 收購江西青春康源製藥有限公司65%股權
TIANJIN DEV: Discloseable Transaction - Acquisition of 65% Equity Interest in Jiangxi Qingchun Kangyuan Pharmaceutical Co., Ltd.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.